These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

228 related items for PubMed ID: 10230181

  • 21. Onset of efficacy of long-acting psychostimulants in pediatric attention-deficit/hyperactivity disorder.
    Brams M, Mao AR, Doyle RL.
    Postgrad Med; 2008 Sep; 120(3):69-88. PubMed ID: 18824827
    [Abstract] [Full Text] [Related]

  • 22. Safety of stimulant treatment in attention deficit hyperactivity disorder: part II.
    Merkel RL.
    Expert Opin Drug Saf; 2010 Nov; 9(6):917-35. PubMed ID: 20615078
    [Abstract] [Full Text] [Related]

  • 23. Effect of stimulant medications for attention-deficit/hyperactivity disorder on later substance use and the potential for stimulant misuse, abuse, and diversion.
    Faraone SV, Wilens TE.
    J Clin Psychiatry; 2007 Nov; 68 Suppl 11():15-22. PubMed ID: 18307377
    [Abstract] [Full Text] [Related]

  • 24. Efficacy of stimulants in adult ADHD.
    Maidment ID.
    Ann Pharmacother; 2003 Dec; 37(12):1884-90. PubMed ID: 14632541
    [Abstract] [Full Text] [Related]

  • 25. Stimulants: use and abuse in the treatment of attention deficit hyperactivity disorder.
    Fone KC, Nutt DJ.
    Curr Opin Pharmacol; 2005 Feb; 5(1):87-93. PubMed ID: 15661631
    [Abstract] [Full Text] [Related]

  • 26. Stimulant treatment of adult attention-deficit/hyperactivity disorder.
    Spencer T, Biederman J, Wilens T.
    Psychiatr Clin North Am; 2004 Jun; 27(2):361-72. PubMed ID: 15064002
    [Abstract] [Full Text] [Related]

  • 27. Growth on stimulant medication; clarifying the confusion: a review.
    Poulton A.
    Arch Dis Child; 2005 Aug; 90(8):801-6. PubMed ID: 16040876
    [Abstract] [Full Text] [Related]

  • 28. Cardiovascular risk of stimulant treatment in pediatric attention-deficit/hyperactivity disorder: update and clinical recommendations.
    Hammerness PG, Perrin JM, Shelley-Abrahamson R, Wilens TE.
    J Am Acad Child Adolesc Psychiatry; 2011 Oct; 50(10):978-90. PubMed ID: 21961773
    [Abstract] [Full Text] [Related]

  • 29. Long-term use of stimulants in children with attention deficit hyperactivity disorder: safety, efficacy, and long-term outcome.
    Hechtman L, Greenfield B.
    Paediatr Drugs; 2003 Oct; 5(12):787-94. PubMed ID: 14658920
    [Abstract] [Full Text] [Related]

  • 30. Stimulants and the developing brain.
    Andersen SL.
    Trends Pharmacol Sci; 2005 May; 26(5):237-43. PubMed ID: 15860370
    [Abstract] [Full Text] [Related]

  • 31. Long-term effects of stimulant medications on the brain: possible relevance to the treatment of attention deficit hyperactivity disorder.
    Vitiello B.
    J Child Adolesc Psychopharmacol; 2001 May; 11(1):25-34. PubMed ID: 11322742
    [Abstract] [Full Text] [Related]

  • 32. Does stimulant medication decrease the lower extremity response times of children with and without attention-deficit/hyperactivity disorder?
    Brasić JR.
    Percept Mot Skills; 2007 Feb; 104(1):67-8. PubMed ID: 17450965
    [Abstract] [Full Text] [Related]

  • 33. [Follow-up of the MTA-study in children with ADHD: what do the data tell us, and what not?].
    Buitelaar JK.
    Tijdschr Psychiatr; 2010 Feb; 52(4):255-7. PubMed ID: 20503166
    [No Abstract] [Full Text] [Related]

  • 34. [Reaction on 'Follow-up of the MTAstudy in children with ADHD: what do the data tell us, and what not?'].
    Nieweg EH.
    Tijdschr Psychiatr; 2010 Feb; 52(8):601-3; author reply 603-5. PubMed ID: 20698001
    [No Abstract] [Full Text] [Related]

  • 35. Management of a hyperactive teen and cardiac safety.
    Sowinski H, Karpawich PP.
    Pediatr Clin North Am; 2014 Feb; 61(1):81-90. PubMed ID: 24267459
    [Abstract] [Full Text] [Related]

  • 36. Attention-deficit/hyperactivity disorder treatment: what are the long-term cardiovascular risks?
    Hammerness PG, Karampahtsis C, Babalola R, Alexander ME.
    Expert Opin Drug Saf; 2015 Apr; 14(4):543-51. PubMed ID: 25648243
    [Abstract] [Full Text] [Related]

  • 37. Appetite and weight in children treated for ADHD.
    Callaghan RS.
    J Am Acad Child Adolesc Psychiatry; 1999 Jul; 38(7):792-3. PubMed ID: 10405493
    [No Abstract] [Full Text] [Related]

  • 38. Paying attention to stimulants: height, weight, and cardiovascular monitoring in clinical practice.
    Towbin K.
    J Am Acad Child Adolesc Psychiatry; 2008 Sep; 47(9):977-80. PubMed ID: 18580503
    [No Abstract] [Full Text] [Related]

  • 39. Impact of Central Nervous System Stimulant Medication Use on Growth in Pediatric Populations with Attention-Deficit/Hyperactivity Disorder: A Review.
    Troksa K, Kovacich N, Moro M, Chavez B.
    Pharmacotherapy; 2019 Jun; 39(6):665-676. PubMed ID: 30368860
    [Abstract] [Full Text] [Related]

  • 40. Stimulant Medications and Sleep for Youth With ADHD: A Meta-analysis.
    Kidwell KM, Van Dyk TR, Lundahl A, Nelson TD.
    Pediatrics; 2015 Dec; 136(6):1144-53. PubMed ID: 26598454
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 12.